Dr. Farid Menaa

Fluorotronics, Inc., USA

Email: dr.fmenaa@gmail.com 

Qualifications

2004 Ph.D., Doctoral School “G2ID” & CEA, Paris, France

1998 M.Sc., School of Medicine & INSERM, Paris, France

1997 B.Sc., School of Medicine of Paris, France

1996 B.Sc., Institute of Technology (IUT), Caen, France

Publications (Selected)

1. Sharif A, Akhtar N, Khan MS, Menaa A, Menaa B, Khan BA, Menaa F. Formulation and evaluation on human skin of a water-in-oil emulsion containing Muscat hamburg black grape seed extract**. Int J Cosmet Sci. 2015; 37(2):253-8. (**featured article)
2. Cruz PR, Lira RP, Pereira Filho SA, Souza BB, Mitsuushi FN, Menaa F, Fertrin KY, Vasconcellos JP, Conran N, Costa FF, Melo MB. Increased circulating PEDF and low sICAM-1 are associated with sickle cell retinopathy. Blood Cells Mol Dis. 2015; 54(1):33-7.
3. Menaa F, Abdelghani A, Menaa B. Graphene nanomaterials as biocompatible and conductive scaffolds for stem cells: impact for tissue engineering and regenerative medicine. J Tissue Eng Regen Med. 2014 Jun 11.
4. Shahrokhi S, Daneshmandi S, Menaa F. Tumor necrosis factor-α/CD40 ligand-engineered mesenchymal stem cells greatly enhanced the antitumor immune response and lifespan in mice. Hum Gene Ther. 2014 ;25(3):240-53.
5. Menaa F. Stroke in sickle cell anemia patients: A need for multidisciplinary approaches. Atherosclerosis. 2013; 229(2):496-503.
6. Menaa F. Latest approved therapies for metastatic melanoma: what comes next? J Skin Cancer. 2013; 2013:735282.
7. Menaa F, Menaa A, Tréton J, Menaa B. Technological approaches to minimize industrial trans fatty acids in foods. J Food Sci. 2013; 78(3):R377-86.
8. Menaa F, Menaa A, Menaa B, Tréton J. Trans-fatty acids, dangerous bonds for health? A background review paper of their use, consumption, health implications and regulation in France**. Eur J Nutr. 2013; 52(4):1289-302. (**featured article)
9. Shahrokhi S*, Menaa F*, Alimoghaddam K, McGuckin C, Ebtekar M. Insights and hopes in umbilical cord blood stem cell transplantations. J Biomed Biotechnol. 2012; 2012:572821. (*equal contribution)
10. Mahamuni SP, Khose RD, Menaa F, Badole SL. Therapeutic approaches to drug targets in hyperlipidemia. BioMedicine. 2012; 2(4):137-146.
11. Menaa F, Menaa B. Development of mitotane lipid nanocarriers and enantiomers: two-in-one solution to efficiently treat adreno-cortical carcinoma**. Curr Med Chem. 2012; 19(34):5854-62. (**featured article)
12. Menaa F, Braghini CA, Vasconcellos JP, Menaa B, Costa VP, Figueiredo ES, Melo MB. Keeping an eye on myocilin: a complex molecule associated with primary open-angle glaucoma susceptibility. Molecules. 2011; 16(7):5402-21.
13. Menaa F, Menaa B, Sharts O. Development of carbon-fluorine spectroscopy for pharmaceutical and biomedical applications**. Faraday Discuss. 2011; 149:269-78; discussion 333-56. (**featured article)
14. Menaa B, Montoneri C, Menaa F, Montoneri E, Boffa V and Sharts N.O: Protein helical structure enhancement in biocompatible fluoro-phosphanate-based nanoporous silica glasses assessed by circular dichroism spectroscopy. Int. J. Nanotechnol. 2011; 8:471-91.
15. Guimarães CA, Menaa F, Menaa B, Quenca-Guillen J, Matos J do R, Mercuri LP, Briaz AB, Rossetti FC, Kedor-Hackmann ER and Santoro MIRM. Comparative Physical-chemical characterization of encapsulated isotretinoin products assessed by particle size distribution and thermal behavior analysis. Thermochimica Acta. 2010; 505:73-8.
16. Menaa B, Menaa F, Guimarães CA and Sharts O: Silica-based nanoporous sol-gel glasses: from bioencapsulation to protein folding studies**. Int. J. Nanotechnol. 2010; 7(1):1-45. (**featured article)
17. Boucharaba A, Guillet B, Menaa F, Hneino M, van Wijnen AJ, Clézardin P, Peyruchaud O. Bioactive lipids lysophosphatidic acid and sphingosine 1-phosphate mediate breast cancer cell biological functions through distinct mechanisms. Oncol Res. 2009;18(4):173-84.
18. Menaa B, Miyagawa Y, Takahashi M, Herrero M, Rives V, Menaa F, Eggers DK. Bioencapsulation of apomyoglobin in nanoporous organosilica sol-gel glasses: influence of the siloxane network on the conformation and stability of a model protein. Biopolymers. 2009; 91(11):895-906.